Experimental esophagitis affects intracellular calcium stores in the cat lower esophageal sphincter

Am J Physiol. 1997 Jun;272(6 Pt 1):G1523-9. doi: 10.1152/ajpgi.1997.272.6.G1523.

Abstract

We previously showed that lower esophageal spincter (LES) tone depends on spontaneous production of inositol 1,4,5-trisphosphate (IP3) and release of intracellular Ca2+ and that acute experimental esophagitis reduces LES tone and IP3 production, suggesting damage to mechanisms responsible for release of Ca2+ from intracellular stores. In the present investigation, we examined the possibility that mechanisms responsible for Ca2+ storage or uptake may also be damaged. LES circular muscle cells were isolated by enzymatic digestion. Contraction was measured in response to IP3 and thapsigargin, which enhances release of Ca2+ from intracellular stores, and in response to calmodulin and to diacylglycerol. In addition, normal cells were incubated in thapsigargin to assess the effect of depletion of intracellular Ca2+ stores on contractile response. Contraction in response to IP3 and thapsigargin was reduced in experimental esophagitis, but contraction in response to calmodulin or diacylglycerol was not. Acetylcholine (ACh)-induced contraction of normal cells was inhibited by the calmodulin antagonist CGS-9343B but not by 1-(5-isoquinolinesulfonyl)-2-methyl-piperazine dihydrochloride (H-7). In contrast, in cells from animals with esophagitis or in thapsigargin-treated cells from normal animals, ACh-induced contraction was inhibited by H-7 and not by CGS-9343B. We conclude that experimental esophagitis may damage intracellular Ca2+ stores in the LES and change the intracellular contractile pathways activated by ACh from calmodulin dependent in normal cells to protein kinase C dependent in esophagitis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Acetylcholine / pharmacology
  • Analysis of Variance
  • Animals
  • Benzimidazoles / pharmacology
  • Calcium / metabolism*
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / pharmacology
  • Cats
  • Diglycerides / pharmacology
  • Esophagitis / physiopathology*
  • Esophagogastric Junction / drug effects
  • Esophagogastric Junction / physiology
  • Esophagogastric Junction / physiopathology*
  • Female
  • In Vitro Techniques
  • Inositol 1,4,5-Trisphosphate / pharmacology
  • Kinetics
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • Muscle, Smooth / physiopathology*
  • Thapsigargin / pharmacology
  • Time Factors

Substances

  • Benzimidazoles
  • Calmodulin
  • Diglycerides
  • 1,2-dioctanoylglycerol
  • CGS 9343B
  • Thapsigargin
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Inositol 1,4,5-Trisphosphate
  • Acetylcholine
  • Calcium